Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Complete Genomics Maps Processes with Lanner

Published: Monday, July 29, 2013
Last Updated: Monday, July 29, 2013
Bookmark and Share
Human genome company selects WITNESS predictive simulation technology to support decision-making and boost throughput.

Lanner announced that Complete Genomics has invested in its WITNESS predictive simulation platform.  The agreement means WITNESS will simulate and optimise business processes at Complete Genomics to enhance the provision of highly accurate, human genome data, ready for interpretation, to biological researchers.

Having selected WITNESS based on its ability to rapidly model the complex, interconnected processes used to deliver accurate DNA sequencing, Matt Morenzoni, Biomolecular Systems Scientist, Complete Genomics comments, “In an industry driven by innovation, precision and speed it is imperative that the best business outcomes are found most effectively.”

Mandy Tague, Lanner director of business development, says, “By choosing predictive simulation to gain insight into the operations of their business, Complete Genomics will be able to make confident decisions that will allow them to meet the increasing demand for their services.”

She continues, “Experimenting with the firm's end-to-end service methods that include process automation, sample preparation, computing infrastructure, and service delivery technology allows Complete Genomics to maximise throughput.   This provides the firm's research clients with highly accurate genomic data, assembled and annotated, ready for biological interpretation with optimum efficiency.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos